巴氟替尼

Bafetinib

未知生产厂商

Bafetinib has been used in trials studying the treatment of Adult Gliosarcoma, Adult Mixed Glioma, Adult Glioblastoma, Chronic Myeloid Leukemia, and Acute Lymphocytic Leukemia, among others.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Bafetinib has been used in trials studying the treatment of Adult Gliosarcoma, Adult Mixed Glioma, Adult Glioblastoma, Chronic Myeloid Leukemia, and Acute Lymphocytic Leukemia, among others.

技术标识符

化学式: C₃₀H₃₁F₃N₈O
CAS 编号: 859212-16-1
UNII ID: NVW4Z03I9B

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

BOSUTINIB, SUNITINIB, TIVOZANIB, IMATINIB, NILOTINIB, REBASTINIB OR BAFETINIB FOR PREVENTING AND/OR TREATING AMYOTROPHIC LATERAL SCLEROSIS
EP 3789027 A1申请人: UNIV KYOTO优先权: 2015
CN
EP
US
WO
4 件公开
CHEMICAL SCREEN OF MODULATORS FOR VACCINE ADJUVANTS
EP 4531910 A4申请人: UNIV CHICAGO优先权: 2022
EP
US
WO
3 件公开
Combination treatments for melanoma
US 9561245 B2申请人: UNIV TEXAS优先权: 2013
US
2 件公开
TREATMENTS FOR MELANOMA
US 2014080772 A1申请人: UNIV TEXAS优先权: 2013
US
Screening method of glucagon-like peptide-1 receptor stimulant and application of screened compound
CN 120847037 A申请人: UNIV ANHUI MEDICAL优先权: 2025
CN
Application of Bafetinib as NLRP3 inflammasome activator and in preparation of drugs for preventing and treating fibrosarcoma
CN 120960225 A申请人: BIG HEALTH RES INSTITUTE OF HEFEI INTEGRATED SCIENCES CENTER优先权: 2025
CN

药物